Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.

The aim of this study is to illuminate a novel therapeutic approach by identifying a functional binding target of salinomycin, an emerging anticancer stem cell (CSC) agent, and to help dissect the underlying action mechanisms. By utilizing integrated strategies, we identify that nucleolin (NCL) is likely a salinomycin-binding target and a critical regulator involved in human neuroblastoma (NB) CSC activity. Salinomycin markedly suppresses NB CD34 expression and reduces CD34+ cell population in an NCL-dependent manner via disruption of the interaction of NCL with CD34 promoter. The elevated levels of NCL expression in NB tumors are associated with poor patient survival. Altogether, these results indicate that NCL is likely a novel functional salinomycin-binding target that exhibits the potential to be a prognostic marker for NB therapy.

[1]  E. Wong,et al.  Identification of a panel of genes as a prognostic biomarker for glioblastoma , 2018, EBioMedicine.

[2]  T. Chambers,et al.  Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo. , 2018, European journal of medicinal chemistry.

[3]  S. Oredsson,et al.  The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin , 2018, ACS central science.

[4]  M. Kunnimalaiyaan,et al.  Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro , 2018, BMC Cancer.

[5]  S. Simjee,et al.  A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway , 2018, Molecular and Cellular Biochemistry.

[6]  J. Rascon,et al.  Results of neuroblastoma treatment in Lithuania: a single centre experience , 2017, Acta medica Lituanica.

[7]  D. Birnbaum,et al.  Salinomycin kills cancer stem cells by sequestering iron in lysosomes , 2017, Nature Chemistry.

[8]  S. Oredsson,et al.  Structure-Activity Relationships in Salinomycin: Cytotoxicity and Phenotype Selectivity of Semi-synthetic Derivatives. , 2017, Chemistry.

[9]  S. Oredsson,et al.  Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids. , 2016, ACS medicinal chemistry letters.

[10]  S. Oredsson,et al.  Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs , 2016, BMC Cancer.

[11]  Ana C. Gregório,et al.  Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination. , 2015, Biomaterials.

[12]  N. Cheung,et al.  A distinct gene expression signature characterizes human neuroblastoma cancer stem cells. , 2015, Stem cell research.

[13]  C. Croce,et al.  Human anti-nucleolin recombinant immunoagent for cancer therapy , 2015, Proceedings of the National Academy of Sciences.

[14]  A. Borkhardt,et al.  Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin , 2015, Leukemia.

[15]  Wenwei Zhang,et al.  An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era , 2014, Genome Biology.

[16]  Yonghe Li,et al.  Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β‐catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells , 2014, Journal of cellular biochemistry.

[17]  Fengfei Wang,et al.  Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. , 2013, Current medicinal chemistry.

[18]  S. Asuthkar,et al.  Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer , 2013, Molecular biology of the cell.

[19]  F. Westermann,et al.  Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma , 2013, Cell Death and Disease.

[20]  Cord Naujokat,et al.  Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.

[21]  S. Asuthkar,et al.  Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Regulation of WNT/β-Catenin Signaling Is Enhanced in Irradiated Medulloblastoma Cells* , 2012, The Journal of Biological Chemistry.

[22]  R. Lu,et al.  Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway* , 2011, The Journal of Biological Chemistry.

[23]  A. Hovanessian,et al.  Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type , 2011, BMC Cancer.

[24]  A. Borkhardt,et al.  Rb and nucleolin antagonize in controlling human CD34 gene expression. , 2011, Cellular signalling.

[25]  T. Kipps,et al.  Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells , 2011, Proceedings of the National Academy of Sciences.

[26]  Lorenzo Rosasco,et al.  UvA-DARE ( Digital Academic Repository ) A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients , 2010 .

[27]  J. H. Park,et al.  High expression of large-conductance Ca2+-activated K+ channel in the CD133+ subpopulation of SH-SY5Y neuroblastoma cells. , 2010, Biochemical and biophysical research communications.

[28]  G. Opelz,et al.  Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. , 2010, Biochemical and biophysical research communications.

[29]  J. Pelletier,et al.  Target identification using drug affinity responsive target stability (DARTS). , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Opelz,et al.  Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.

[31]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[32]  J. Mora,et al.  Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells , 2009, BMC Developmental Biology.

[33]  R. Lewensohn,et al.  The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[34]  P. Wernet,et al.  Nucleolin Regulates Gene Expression in CD34-positive Hematopoietic Cells* , 2007, Journal of Biological Chemistry.

[35]  N. Cheung,et al.  Characteristics of stem cells from human neuroblastoma cell lines and in tumors. , 2004, Neoplasia.

[36]  J. Feigon,et al.  Solution structures of stem-loop RNAs that bind to the two N-terminal RNA-binding domains of nucleolin. , 2003, Nucleic acids research.

[37]  B. Hero,et al.  Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma , 2002, Bone Marrow Transplantation.

[38]  J. Borowiec,et al.  Formation of a Complex between Nucleolin and Replication Protein a after Cell Stress Prevents Initiation of DNA Replication , 2000, The Journal of cell biology.

[39]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[40]  F. Riddell,et al.  The transport of Na+ and K+ ions through phospholipid bilayers mediated by the antibiotics salinomycin and narasin studied by 23Na- and 39K-NMR spectroscopy. , 1990, Biochimica et biophysica acta.

[41]  M. Mitani,et al.  Salinomycin: a new monovalent cation ionophore. , 1975, Biochemical and biophysical research communications.

[42]  H. Hwang,et al.  Drug affinity responsive target stability (DARTS) for small-molecule target identification. , 2015, Methods in molecular biology.

[43]  S. Dimitrov,et al.  Functions of the histone chaperone nucleolin in diseases. , 2007, Sub-cellular biochemistry.

[44]  N. Tuteja,et al.  Nucleolin: a multifunctional major nucleolar phosphoprotein. , 1998, Critical reviews in biochemistry and molecular biology.